Publication: The effect of PCOS status on atherosclerosis markers and cardiovascular disease risk factors in young women with vitamin D deficiency
| dc.contributor.author | YOLDEMİR, AHMET TEVFİK | |
| dc.contributor.authors | Atasayan, Kemal; Yoldemir, Tevfik | |
| dc.date.accessioned | 2022-03-12T22:42:41Z | |
| dc.date.accessioned | 2026-01-11T11:11:58Z | |
| dc.date.available | 2022-03-12T22:42:41Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Objective To investigate whether polycystic ovary syndrome (PCOS) had further deteriorating influence on endothelial function or cardiometabolic parameters in women with vitamin D deficiency during reproductive age. Study design The study group was composed of women with PCOS and vitamin D deficiency and insufficiency between the ages of 18 and 35 years. Age and body mass index (BMI)-matched women were chosen as controls. Serum 25(OH) Vit D levels below 20 ng/mL were considered as vitamin D deficiency. The cutoff level of vitamin D insufficiency was suggested at 30 ng/mL. Serum FSH, LH, estradiol, testosterone, DHEA-S, fasting glucose, total cholesterol, HDL, LDL, triglyceride levels were analyzed. Carotid artery intima-media thickness (CIMT) was measured, and the flow-mediated vasodilation (FMD) was calculated. Results CIMT and FMD values in both vitamin D deficiency and insufficiency subgroups showed no significant difference between PCOS and non-PCOS groups. There was a weak negative correlation between BMI, waist/hip ratio, CRP, and 25(OH) Vitamin D. Conclusion PCOS is a heterogeneous disease with different combinations of the diagnostic components. Vitamin D is an important variable for a healthy cardiovascular system. We did not find any difference in early atherosclerotic markers and cardiometabolic features between PCOS and non-PCOS group with Vitamin D deficiency. | |
| dc.identifier.doi | 10.1080/09513590.2020.1826428 | |
| dc.identifier.eissn | 1473-0766 | |
| dc.identifier.issn | 0951-3590 | |
| dc.identifier.pubmed | 32996333 | |
| dc.identifier.uri | https://hdl.handle.net/11424/236250 | |
| dc.identifier.wos | WOS:000573983100001 | |
| dc.language.iso | eng | |
| dc.publisher | TAYLOR & FRANCIS LTD | |
| dc.relation.ispartof | GYNECOLOGICAL ENDOCRINOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | PCOS | |
| dc.subject | vitamin D deficiency | |
| dc.subject | vitamin D insufficiency | |
| dc.subject | CIMT | |
| dc.subject | FMD | |
| dc.subject | POLYCYSTIC-OVARY-SYNDROME | |
| dc.subject | ENDOTHELIAL FUNCTION | |
| dc.subject | INSULIN-RESISTANCE | |
| dc.subject | D SUPPLEMENTATION | |
| dc.subject | METABOLIC DISTURBANCES | |
| dc.subject | ANDROGEN LEVELS | |
| dc.subject | METAANALYSIS | |
| dc.subject | DIAGNOSIS | |
| dc.title | The effect of PCOS status on atherosclerosis markers and cardiovascular disease risk factors in young women with vitamin D deficiency | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 229 | |
| oaire.citation.issue | 3 | |
| oaire.citation.startPage | 225 | |
| oaire.citation.title | GYNECOLOGICAL ENDOCRINOLOGY | |
| oaire.citation.volume | 37 |
